Scancell Hldgs Plc (SCLP)

London
23.32
+0.25(+1.10%)
  • Volume:
    327,547
  • Bid/Ask:
    22.50/23.50
  • Day's Range:
    23.32 - 23.32

SCLP Overview

Prev. Close
22.75
Day's Range
23.32-23.32
Revenue
-
Open
22.75
52 wk Range
5.55-29
EPS
-0.01
Volume
327,547
Market Cap
182.14M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
934,549
P/E Ratio
-
Beta
0.5
1-Year Change
230.31%
Shares Outstanding
791,917,828
Next Earnings Date
10 Oct 2021
What is your sentiment on Scancell Hldgs Plc?
or
Vote to see community's results!

Scancell Hldgs Plc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Scancell Hldgs Plc Company Profile

Scancell Hldgs Plc Company Profile

Employees
22

Scancell Holdings plc engages in the discovery and development of novel vaccines for the treatment of various cancers. The company’s product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 that is in phase I/II combination trials for the treatment of non-small cell lung cancer; and Modi-1, which is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2 that is in pre-clinical trial for the treatment of multiple solid tumors. The company has a research collaboration agreement with BioNTech to develop T-cell receptor based therapeutics; licensing and collaboration agreement with ISA Pharmaceuticals B.V. to use ISA’s AMPLIVANT adjuvant technology for the development and commercialization of Modi-1; and collaboration agreements with Cobra Biologics, Centre for Research on Global Virus Infections, the University of Nottingham, and the Nottingham Trent University to develop a vaccine for COVID-19. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.

Read More
  • how long till SCLP vaccine is on market ?one more year?
    3
    • Market starting to realise that different types of vaccines have value. This company has developed a vaccine that should be a longer term answer...
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.